BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30088019)

  • 1. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit
    Jin X; Zhou J; Richey G; Wang M; Hong SMC; Hong SH
    J Microbiol Biotechnol; 2021 Jan; 31(1):130-136. PubMed ID: 33046677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state.
    Marques CN; Morozov A; Planzos P; Zelaya HM
    Appl Environ Microbiol; 2014 Nov; 80(22):6976-91. PubMed ID: 25192989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MazEF toxin-antitoxin proteins alter Escherichia coli cell morphology and infrastructure during persister formation and regrowth.
    Cho J; Carr AN; Whitworth L; Johnson B; Wilson KS
    Microbiology (Reading); 2017 Mar; 163(3):308-321. PubMed ID: 28113053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persister cells.
    Lewis K
    Annu Rev Microbiol; 2010; 64():357-72. PubMed ID: 20528688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
    Sulaiman JE; Hao C; Lam H
    J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Granulocyte Macrophage Colony-Stimulating Factor Enhances Antibiotic Susceptibility of Pseudomonas aeruginosa Persister Cells.
    Choudhary GS; Yao X; Wang J; Peng B; Bader RA; Ren D
    Sci Rep; 2015 Nov; 5():17315. PubMed ID: 26616387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.
    Dörr T; Vulić M; Lewis K
    PLoS Biol; 2010 Feb; 8(2):e1000317. PubMed ID: 20186264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
    Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HigB of
    Li M; Long Y; Liu Y; Liu Y; Chen R; Shi J; Zhang L; Jin Y; Yang L; Bai F; Jin S; Cheng Z; Wu W
    Front Cell Infect Microbiol; 2016; 6():125. PubMed ID: 27790409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
    Hofsteenge N; van Nimwegen E; Silander OK
    BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.
    Keren I; Shah D; Spoering A; Kaldalu N; Lewis K
    J Bacteriol; 2004 Dec; 186(24):8172-80. PubMed ID: 15576765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-Dependent Persister Formation in Escherichia coli.
    Shan Y; Brown Gandt A; Rowe SE; Deisinger JP; Conlon BP; Lewis K
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation.
    Korch SB; Hill TM
    J Bacteriol; 2006 Jun; 188(11):3826-36. PubMed ID: 16707675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combatting bacterial infections by killing persister cells with mitomycin C.
    Kwan BW; Chowdhury N; Wood TK
    Environ Microbiol; 2015 Nov; 17(11):4406-14. PubMed ID: 25858802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
    Li Y; Zhang Y
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2092-9. PubMed ID: 17420206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis.
    Hansen S; Vulić M; Min J; Yen TJ; Schumacher MA; Brennan RG; Lewis K
    PLoS One; 2012; 7(6):e39185. PubMed ID: 22720069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
    Hansen S; Lewis K; Vulić M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2718-26. PubMed ID: 18519731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.